Owner Columbia Laboratories (Bermuda) Limited

Inventors Bologna, William J.; Levine, Howard L.

Agent Spruson & Ferguson

Pub. Number AU-B-2003233066

PCT Number PCT/EP03/04316

PCT Pub. Number WO2004/037229

Priority 60/438,501 08.01.03 US; 10/278,912 24.10.02 US

Filing date 25 April 2003

Wipo publication date 13 May 2004

Acceptance publication date 19 November 2009

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 31/00 (2006.01)

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/192 (2006.01)

A61K 31/245 (2006.01)

A61K 31/554 (2006.01) - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets